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Oligoclonal B Lymphocyte Expansion in the Synovium
of a Patient With Behc¸et’s Disease
Chang Hee Suh, Yong Beom Park, Jungsik Song, Chan Hee Lee, and Soo Kon Lee
Objective. Plasma cell infiltration is observed in
recurrent arthritis associated with Behc¸et’s disease
(BD). The immune mechanism underlying B lymphocyte
proliferation in the synovium is unclear. One hypothesis
involves nonspecific polyclonal activation and another
involves antigen-driven activation. The present study
was undertaken to test both hypotheses and identify
immunoglobulin genes that are clonally expanded in the
synovium.
Methods. Peripheral blood lymphocytes (PBL) and
synovial cells from a patient with BD and PBL from a
healthy control subject were obtained. Complementarity-
determining region 3 (CDR3) fingerprinting analysis and
nucleotide sequence analysis of Ig transcripts derived
from clonally expanded B lymphocytes were performed in
parallel.
Results. Of 44 m heavy chain clones of the VH4
family identified in the synovial tissue from the BD
patient, 8 clones showed identical nucleotide sequences,
and therefore, 18.2% were clonally expanded. For g
heavy chain, 4 of 50 clones of the VH3 family showed
nearly identical sequences; therefore, 4–8% were
clonally expanded. The k light chain did not show a
dominant band, but a clone with a 12–amino acid CDR3
showed 3% clonal expansion. Somatic mutations were
frequently observed, with a high ratio of replacement to
silent mutations in the CDRs compared with the frame-
work regions. Three Ig genes expressed in the clonally
expanded B lymphocytes were derived from germline
gene segments reported to be involved in the production
of autoantibodies.
Conclusion. These results support the hypothesis
that antigen-driven clonal B lymphocyte proliferation oc-
curs in the synovium in BD. Immunoglobulin transcripts
clonally expanded in the synovium were identified.
Behc¸et’s disease (BD) is a chronic syndrome that
causes recurrent oral and genital ulcers, skin rashes, and
uveitis. BD also affects various other organs, including
the joints. The disease is proposed to be of viral or
bacterial origin, but its exact cause is not clear. Several
studies suggest that there are abnormalities of the cells
involved in cell-mediated immunity, including T lympho-
cytes, monocyte/macrophages, and neutrophils (1,2).
Abnormalities of humoral immunity have also been
reported. IgM and C3 have been shown to be deposited
in oral ulcers and erythema nodosum–like lesions in BD
patients (3). In the peripheral blood, the B lymphocytes
that spontaneously secrete immunoglobulins are in-
creased, yet mitogen-induced proliferation is decreased
(4). Increases in serum Ig and autoantibodies, such as
antinuclear antibodies and anti–endothelial cell antibod-
ies, have also been reported (5).
Plasma cells infiltrate the synovial tissue in BD,
and apparent germinal centers are observed in the
arthritic tissue (6,7). These findings, coupled with the
knowledge that Ig accumulate on the surface of the
synovial tissue, suggest that B lymphocytes are involved
in the development of arthritis. However, the cause of
proliferation and infiltration of B lymphocytes in the
synovium is not known.
The third complementarity-determining region
(CDR3) of Ig is generated by the rearrangement of
germline V–(D)–J gene segments. This allows the length
of CDR3 to be used as a clonal marker (8). CDR3
fingerprinting analysis, a 2-stage anchored polymerase
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chain reaction (PCR), can be used to investigate the
clonality of B and T lymphocytes.
To determine whether the B lymphocytes in the
synovial tissues of BD patients with arthritis have under-
gone clonal expansion, clonality was examined using
CDR3 fingerprinting analysis of the Ig heavy and light
chains expressed in these tissues. To identify the germline
origin, the nucleotide sequences of Ig genes showing clonal
expansion were analyzed. Our results suggest that B lym-
phocytes proliferate in response to an antigen and are
involved in the pathogenic mechanism of arthritis in BD.
PATIENTS AND METHODS
Study subjects. The patient, a 37-year-old woman,
came to our hospital because of a 3-year history of recurrent
knee arthritis. Three years previously, she had been diagnosed
as having BD, with aphthous orogenital ulcers and erythema
nodosum–like skin lesions, according to the diagnostic criteria
of the International Study Group (9). Serum rheumatoid
factor was negative. Arthroscopic synovectomy of the knee was
performed because of her recurrent arthritis, although she had
been treated with antiinflammatory drugs. There was mild
synovial hypertrophy and some inflammatory cells in the
synovium, but no granuloma was seen.
As a control, peripheral blood was obtained from a
healthy 32-year-old woman who had no history of orogenital
ulcerations or other autoimmune diseases.
CDR3 fingerprinting analysis. Total RNA was ex-
tracted from the peripheral blood lymphocytes (PBL) and
synovial cells (SC) obtained from the BD patient, as well as
from the PBL obtained from the control subject. First-strand
complementary DNA (cDNA) was prepared with an oligo(dT)
primer. The first-stage PCR was performed with a set of
family-specific sense and antisense primers (Table 1) to am-
plify the variable regions of the Ig. The conditions of the
first-stage PCR were 1 cycle of denaturation at 94°C for 3
minutes, 30 cycles of denaturation at 94°C for 1 minute,
annealing at 62°C for 1 minute, extension at 72°C for 1 minute,
and a final extension at 72°C for 7 minutes. The predicted PCR
products were ;500 bp and were confirmed by 1.5% agarose
gel electrophoresis.
Second-stage PCR was performed with the first-stage
PCR products to amplify the CDR3 with a set of primers. The
forward internal primer included LSK56, LSK64, or LSK65;
the g32P-dATP–labeled reverse internal primer included
LSK57 or LSK66 (Table 1). The conditions of the second-stage
PCR were 1 cycle of denaturation at 94°C for 3 minutes, 15
cycles of denaturation at 94°C for 1 minute, annealing at 50°C
for 1 minute, extension at 72°C for 1 minute, and a final
extension at 72°C for 7 minutes. Polyacrylamide gel (6%)
electrophoresis was done with the second-stage PCR products.
The distribution of the CDR3 length was observed visually. A
predominant band was defined as the only dominant band in a
specific family.
Colony hybridization. To identify the CDR3 sequence
of the predominant band, we cut the band and eluted the
DNA. The second-stage PCR was performed again to amplify
the eluted DNA, and subsequent ligation into a pT7 Blue T
vector (Novagen, Madison, WI) and transformation into Esch-
erichia coli (DH5a) were performed. After sequencing, a
CDR3 probe was synthesized to find the whole Ig variable-
region sequence. After ligating the first-stage PCR product of
the same family and transforming it into E coli, colony
hybridization was performed with the g32P-dATP–labeled
CDR3 probe. A probe-positive colony was identified and then
sequenced.






gene of origin Orientation Sequence, 59339
LSK44 VH1 Leader Sense CGGAATTCATGGACTGGACCTGGAGG(A/G)TC(C/T)TCT
LSK45 VH2 Leader Sense CGGAATCATGGACA(C/T)ACTTTG(C/T)TCCACGCTCC
LSK46 VH3 Leader Sense CGGAATTCATGGAGT(C/T)TGGGCTGAGCTGG(C/G)TTT
LSK47 VH4 Leader Sense CGGAATTCATGAA(A/G)CA(C/T)CTGTGGTTCTTCCT(C/T)C
LSK48 VH5 Leader Sense CGGAATTCATGGGGTCAACCGCCATCCTCGCCC
LSK49 VH6 Leader Sense CGGAATTCATGTCTGTCTCCTTCCTCATCTTCC
LSK50 Cm CH1(59) Antisense GCTCTAGAAGACGAGGGGGAAAAGGGTT
LSK51 Cg CH1(59) Antisense GCTCTAGAGGAGGAGGGTGCCAGGGG
LSK58 Vk1 Leader Sense CGGAATTCATGGACATGAGGGTCC(C/T)CGCTCAGC
LSK59 Vk2 Leader Sense CGGAATTCATGAGGCTCCCTGCTCAGCTCCTGG
LSK60 Vk3 Leader Sense CGGAATTCATGGAA(A/G)CCCCAGC(G/T)CAGCTTCTCT
LSK61 Vk4 Leader Sense CGGAATTCATGGTGTTGCAGACCCAGGTCTTCA
LSK62 Ck C(59) Antisense GCTCTAGATTTCAACTGCTCATCAGATGG
LSK56 VH1-6 FR3 Sense CGGAATTCACAC(C/G/T)GC(C/T)(A/G)TGTATTACTGTGC
LSK57 JH1-6 JH Antisense GCTCTAGATGA(A/G)GAGAC(A/G)GTGACC
LSK64 Vk1,3,4 FR3 Sense CGGAATTCACTCTCACCATCAGCAG
LSK65 Vk2 FR3 Sense CGGAATTCACACTGAAAATCAGC
LSK66 Ck Proximal to LSK62 Antisense GCTCTAGACAGATGGTGCAGCCAC
* Nucleotides in parentheses indicate sites of degeneracy. FR3 5 framework region 3.
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RESULTS
CDR3 fingerprinting analysis of PBL from the
control subject demonstrated a lack of dominant bands
of the m heavy chain, but 1 dominant band in the VH4
family of the g heavy chain was expressed. The PBL
from the BD patient, however, demonstrated dominant
bands in several families of the m and g chains. The SC
from the BD patient showed dominant bands in nearly
all families of the m and g chains (Figures 1A and B).
The dominant bands of each family in the SC from the
BD patient differed in length from those of the same
family in the patient’s PBL. Clonal predominance was
observed in the SC: the VH4 family of the m chain and
the VH3 family of the g chain. No dominant band was
observed in k light chains, but in the SC, a 12–amino acid
CDR3 band appeared in the Vk3 family (Figure 1C).
After sequencing the predominant band of m and
g heavy chains and the band with the 12–amino acid
CDR3 of the k light chain, we synthesized CDR3
signature probes. Each of the m chain (4m9, 59-CTC-
GGG-ATG-GGA-GCT-TTT-GAT-TTC-39), g chain
(3g15, 59-GCT-CGG-GGA-GTT-ACC-CCT-GAT-
GCT-39), and k light chain (3k12, 59-AAT-AAC-TGG-
CCT-CCG-GAG-GAG-CTC-39) signature probes was
synthesized as a 24-mer.
After colony hybridization with the 4m9 probe, 8
of 44 colonies that had a m-chain variable-region insert
showed identical sequences throughout the whole vari-
able region (7m4-9). In particular, in the VH4 family,
7m4-9 showed 18.2% clonal expansion. This clone con-
sisted of 450 bases and was generated as a result of
recombination of the germline gene V4-39 (94.1% ho-
mology) with a part of the DXP91 gene and the JH3 gene
(Figure 2A). Nongermline-encoded nucleotides were
observed between the VH and D genes and between the
D and JH genes. There were 10 mutations in framework
regions (FRs), and 5 of them were replacement muta-
tions; the ratio of replacement to silent mutations (R:S)
was therefore 1. In CDRs, 8 of 10 mutations were
replacement mutations, and the R:S ratio was 4.
Of 50 colonies having g-chain variable regions, 2
(one of which is 7g3-15) showed identical sequences and
2 others differed from 7g3-15 by only 1 or 2 nucleotides
(Figure 2B). It is probable that these 4 colonies were
Figure 1. Third complementarity-determining region (CDR3) fingerprinting analysis of immunoglobulin m heavy, g heavy, and k light chains. Using
complementary DNA, we amplified the Ig variable region in the first-stage polymerase chain reaction (PCR) and the CDR3 in the second-stage
PCR, and then performed polyacrylamide gel electrophoresis. Peripheral blood lymphocytes (PBL) from the control subject lacked dominant bands
in the m chain but expressed 1 dominant band in the VH4 family of the g chain (A and B). PBL from the Behc¸et’s disease (BD) patient, however,
expressed dominant bands in the VH1 and VH4 families of the m chain and in the VH3, VH4, VH5, and VH6 families of the g chain. In synovial cells
(SC) from the BD patient, the m chain showed dominant bands in the VH1, VH2, VH4, VH5, and VH6 families and the g chain showed dominant
bands in the VH1, VH2, VH3, VH5, and VH6 families (A and B). In the SC, a predominant band was observed in the VH4 family of the m chain and
the VH3 family of the g chain (white asterisk). In terms of the k light chain, the control PBL and the BD PBL and SC showed a similar pattern of
distribution, consisting of 8–11–amino acid CDR3, and dominant bands were not observed visually. A CDR3 band (white asterisk) consisting of 12
amino acids was observed in SC from the BD patient (C), but not in PBL from either the control subject or the BD patient. a.a. 5 amino acid.
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derived from the same clone because we did not use a
proofreading DNA polymerase. In other words, 7g3-15
showed 4–8% clonal expansion in the VH3 family. This
clone, which consisted of 470 bases, was constructed by
recombination of the germline gene V3-30, a part of the
DXP91 gene, and the JH3 gene. The sequence of the VH
gene segment was 95.4% homologous with the V3-30
sequence. Also, nongermline-encoded nucleotide se-
quences were observed. In the FRs, 7 of 12 mutations
were replacement mutations (R:S ratio 1.4). All 6 mu-
tations found in CDRs were replacement mutations.
Of 31 colonies having a k light chain variable
region, only 1 (7k3-12) had a 12–amino acid CDR3 and
nucleotide sequences that were identical to the 3k12
probe (Figure 2C). Therefore, 7k3-12 showed 3% clonal
expansion in the Vk3 family. A 7k3-12 clone consisting of
456 nucleotides was made by recombination of the
germline gene Humkv328h5 with the Jk3 gene. The
Figure 2. The nucleotide sequence of immunoglobulin m heavy, g heavy, and k light chain transcripts, showing clonal expansion in the synovial cells
from the patient with Behc¸et’s disease. The top row is the nucleotide sequence of the germline Ig gene. If the nucleotide sequence of the transcripts
was identical to that of the germline, a dot was printed; if the sequence differed, a letter indicating the mutation was printed. A, Nucleotide sequence
of 7m4-9 IgM transcript clone (GenBank accession no. AF135164). This clone was synthesized by a recombination of germline gene V4-39, DXP91
gene, and JH3 gene. A total of 22 somatic mutations were observed. p 5 7m4-9 and 7 other clones all showed identical nucleotide sequences. B,
Nucleotide sequence of the 7g3-15 IgG transcript clone (GenBank accession no. AF103795). This clone was made by recombining germline gene
V3-30, DXP91 gene, and JH3 gene. Nineteen somatic mutations were observed. # 5 7g3-15 and 1 other clone showed identical nucleotide sequences.
7g3-1 and 7g3-5 differed from 7g3-15 by only 1 and 2 nucleotide sequences, respectively. C, Nucleotide sequence of the 7k3-12 Igk transcript clone
(GenBank accession no. AF103873). Recombining the germline gene Humkv328h5 and the Jk3 gene generated this clone. A total of 12 somatic
mutations were observed. FR 5 framework region; CDR 5 complementarity-determining region.
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sequence of the Vk gene segment showed 96.8% simi-
larity to the Humkv328h5. Interestingly, the 7k3-12 had
a nongermline-encoded nucleotide (GGAGGAGC) be-
tween Vk and Jk gene. There were 7 mutations in FRs,
and 4 of these were replacement mutations (R:S ratio
1.3). In CDRs, there were 3 replacement mutations in a
total of 4 mutations (R:S ratio 3).
DISCUSSION
The clonal dominance of B lymphocytes was rare
in the PBL from the control subject, yet in both the PBL
and the SC from the BD patient, it was abundant.
Several families belonging to m and g chains expressed
various dominant bands in the PBL and the SC from the
BD patient. If it is accepted that the clonal expansion of
B lymphocytes is taking place systemically, this suggests
that the B lymphocyte is involved in the pathogenic
mechanism of BD. This finding coincides with the high
levels of IgG, IgM, and IgA in the blood of patients with
BD (5).
The predominant band in the VH4 family of the m
chain and the VH3 family of the g chain in the SC from
the BD patient showed differences in CDR3 length
compared with the same families in the PBL. These
results suggest that the PBL and SC proliferated in
response to different antigenic epitopes in the BD
patient. Patients with rheumatoid arthritis (RA) have
different patterns of clonal expansion in the PBL and
synovial fluid based on CDR3 fingerprinting analysis
(10), and this difference is more marked in the synovium
(11). It is of interest that clonal predominance was
observed in the PBL from the healthy control subject.
The significance of this finding is not clear, but in a
similar fingerprinting analysis using T lymphocytes from
monozygotic twins, the investigators reported that clonal
expansion might have occurred because of environmen-
tal factors, such as bacterial infection (12).
Unlike the heavy chains, clonal dominance was
not observed for the k light chain. In the k light chain, a
9–amino acid CDR3 was mainly expressed, and the
pattern of distribution did not differentiate between the
BD patient and the control subject. This is presumed to
be because the functional genes in the germline are less
abundant and there is no D gene. What is interesting to
us is that a band corresponding to CDR3 with 12 amino
acids was observed in the Vk3 family of the SC. To our
knowledge, this is the first k light chain transcript that
has a 12–amino acid CDR3. The significance of this
unusually long CDR3 in a patient with BD is not known;
however, a study by Lee et al (13) demonstrated 11–
amino acid CDR3 expressed abundantly in the synovial
tissue of RA patients.
That the clonal dominance observed in the
CDR3 fingerprinting analysis is in fact due to clonal
expansion was demonstrated by the results of colony
hybridization. In the VH4 family of the m chain, there
was 18.2% clonal expansion in the synovium. In the VH3
family of the g chain, 4–8% clonal expansion was
observed. In the Vk3 family, there was 3% clonal
expansion. This study is a PCR-based analysis, so it
cannot be directly compared with a synovial cDNA
library. However, it is comparable in terms of the
percentage of clonal expansion in RA. In the synovium
of RA patients, 2 of 67 g chain recombinants were found
to contain nearly identical VH–DH–JH joins and to share
somatic mutations, showing 3% clonal expansion (14).
Of 64 k light chain recombinants in the cDNA libraries,
3 (5%) had identical nucleotide sequences (15).
B cells that are bound to antigen proliferate and
acquire somatic mutations. These mutations cause the
affinity of the antigen-binding sites to change. In the
case of antibody, the R:S ratio of the FRs must be #1.5
in order to conserve function. However, the R:S ratio is
.2.9 in the CDR3, which means that the clone with high
affinity for antigen is selected (16). Clone 7m4-9 of the
m chain revealed that the R:S ratio was 1 in the FRs but
4 in the CDRs. This phenomenon was also observed with
the g chain (7g3-15). In the FRs, the R:S ratio was 1.4,
but all 6 mutations in the CDRs were replacement
mutations. In the clone 7k3-12, the R:S ratio was 1.4 in
the FRs but 3 in the CDRs. This pattern is understood to
be a result of antigen-specific clonal expansion.
It is interesting that the 3 Ig genes that showed
clonal expansion in the SC were derived from the
germline gene involved in the production of autoanti-
bodies. It has been reported that V4-39 was used for
making an autoantibody against thyroglobulin and
V3-30 was used for making a rheumatoid factor and
anti–double-stranded DNA antibody (17). Humkv328h5
is very similar to humkv328, which is commonly used in
rheumatoid factors. Although these data were derived
from only 1 BD patient and the specificity of the cloned
Ig is not known, they do suggest that B lymphocytes
showing clonal expansion have been selected by an
autoantigen(s) and further suggest an autoimmune
mechanism in BD. In the synovial tissue of RA patients,
evidence of clonal expansion has been reported and was
shown to be used in the production of autoantibodies
(14,15). In future studies in which we recombine the Ig
that showed clonal expansion and study the antigen
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specificity, we should be able to elucidate the pathogen-
esis of BD.
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